» Authors » Luis A Milla

Luis A Milla

Explore the profile of Luis A Milla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 151
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Milla L, Corral L, Rivera J, Zuniga N, Pino G, Nunez-Parra A, et al.
Front Neurosci . 2023 Aug; 17:1213410. PMID: 37599992
Fragile X Syndrome (FXS) is a neurodevelopmental disorder and the leading monogenic cause of autism and intellectual disability. For years, several efforts have been made to develop an effective therapeutic...
2.
Acuna-Castillo C, Barrera-Avalos C, Bachelet V, Milla L, Inostroza-Molina A, Vidal M, et al.
Front Public Health . 2023 Jul; 11:1191377. PMID: 37492136
Introduction: As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an...
3.
Barrera-Avalos C, Briceno P, Valdes D, Imarai M, Leiva-Salcedo E, Rojo L, et al.
iScience . 2021 Dec; 24(12):103520. PMID: 34950860
T cell activation requires the processing and presentation of antigenic peptides in the context of a major histocompatibility complex (MHC complex). Cross-dressing is a non-conventional antigen presentation mechanism, involving the...
4.
Del Campo A, Salamanca C, Fajardo A, Diaz-Castro F, Bustos C, Calfio C, et al.
Molecules . 2021 Oct; 26(20). PMID: 34684731
Type 2 diabetes and obesity are major problems worldwide and dietary polyphenols have shown efficacy to ameliorate signs of these diseases. Anthocyanins from berries display potent antioxidants and protect against...
5.
Barrera-Avalos C, Diaz X, Madrid B, Michelson S, Robles-Planells C, Sanchez-Guerrero G, et al.
Biomed Res Int . 2021 Feb; 2021:6626851. PMID: 33623783
Active immunotherapy against cancer is based on immune system stimulation, triggering efficient and long-lasting antigen-specific immune responses. Immunization strategies using whole dead cells from tumor tissue, containing specific antigens inside,...
6.
Barrera-Avalos C, Mena J, Lopez X, Cappelli C, Neira T, Imarai M, et al.
Immunotherapy . 2021 Jan; 13(4):309-326. PMID: 33397152
Whole dead tumor cells can be used as antigen source and the induction of protective immune response could be enhanced by damage-associated molecular patterns. We generated whole dead tumor cells...
7.
Robles-Planells C, Barrera-Avalos C, Rojo L, Spencer E, Cortez-San Martin M, Matiacevich S, et al.
Biomed Res Int . 2020 Jul; 2020:4045760. PMID: 32626742
Reovirus is known to have an anticancer effect in both the preclinical and clinical assays. Current evidence suggests that the reovirus-mediated impact on tumor growth depends on the activation of...
8.
Robles-Planells C, Sanchez-Guerrero G, Barrera-Avalos C, Matiacevich S, Rojo L, Pavez J, et al.
Mediators Inflamm . 2020 May; 2020:8680692. PMID: 32410869
Oncolytic virus therapy has been tested against cancer in preclinical models and clinical assays. Current evidence shows that viruses induce cytopathic effects associated with fusogenic protein-mediated syncytium formation and immunogenic...
9.
Burgos H, Hernandez A, Constandil L, Rios M, Flores O, Puentes G, et al.
Behav Brain Res . 2019 Feb; 363:182-190. PMID: 30721762
Moderate reduction of dietary protein (from 25% to 8% casein) in pregnant rats, calorically compensated by carbohydrates, gives rise to 'hidden prenatal malnutrition' (HPM) in the offspring since it does...
10.
Villanueva A, Falcon P, Espinoza N, R L, Milla L, Hernandez-SanMiguel E, et al.
Oncotarget . 2016 Dec; 8(6):9767-9782. PMID: 28038459
Neogenin-1 (NEO1) is a transmembrane receptor involved in axonal guidance, angiogenesis, neuronal cell migration and cell death, during both embryonic development and adult homeostasis. It has been described as a...